tetano
Editor, Senior Moderator
Australas J Ageing
. 2021 Oct 20.
doi: 10.1111/ajag.13003. Online ahead of print.
Risk factors for myocardial injury at admission of 325 patients with coronavirus disease 2019 in Shanghai, China
Xue Mei[SUP] 1 [/SUP], Yuanyuan Ji[SUP] 2 [/SUP], Zhiping Qian[SUP] 1 [/SUP], Yun Ling[SUP] 3 [/SUP], Hui Zhu[SUP] 1 [/SUP], Xingcheng Zhao[SUP] 4 [/SUP], Fang Shen[SUP] 5 [/SUP], Qingnian Xu[SUP] 6 [/SUP], Zhengguo Zhang[SUP] 1 [/SUP], Xingxia Cheng[SUP] 1 [/SUP], Yu Liu[SUP] 1 [/SUP], Hongying Guo[SUP] 1 [/SUP], Ying Zou[SUP] 1 [/SUP], Jiefei Wang[SUP] 1 [/SUP], Yuyi Zhang[SUP] 1 [/SUP], Lie Xu[SUP] 3 [/SUP], Hongzhou Lu[SUP] 7 [/SUP]
Affiliations
Abstract
Objective: Myocardial injury leads to higher mortality in COVID-19, but the causes and risk factors are variable. We evaluated the potential risk factors for myocardial injury in COVID-19 patients to improve treatment strategies and reduce mortality.
Methods: This retrospective analysis enrolled 325 COVID-19 patients in Shanghai, China.
Results: The median age in our cohort was 51 [range 15-88] years, 26 (8%) were critically ill, and 177 patients (19.7%) had myocardial injury. The myocardial injury group comprised older, more critically ill patients with hypertension, other comorbidities, history of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use, lower peripheral blood lymphocyte count and higher D-dimer levels. Binary logistic regression analysis identified only age was an independent risk factor for myocardial injury (odds ratio 1.019; 95% confidence interval 1.003-1.036; age increase by 1 year = myocardial injury risk increase by 1.9%).
Conclusion: Older age was associated with a higher incidence of myocardial injury for COVID-19 patients.
Keywords: COVID-19; SARS-CoV-2; myocardial injury; novel coronavirus pneumonia.
. 2021 Oct 20.
doi: 10.1111/ajag.13003. Online ahead of print.
Risk factors for myocardial injury at admission of 325 patients with coronavirus disease 2019 in Shanghai, China
Xue Mei[SUP] 1 [/SUP], Yuanyuan Ji[SUP] 2 [/SUP], Zhiping Qian[SUP] 1 [/SUP], Yun Ling[SUP] 3 [/SUP], Hui Zhu[SUP] 1 [/SUP], Xingcheng Zhao[SUP] 4 [/SUP], Fang Shen[SUP] 5 [/SUP], Qingnian Xu[SUP] 6 [/SUP], Zhengguo Zhang[SUP] 1 [/SUP], Xingxia Cheng[SUP] 1 [/SUP], Yu Liu[SUP] 1 [/SUP], Hongying Guo[SUP] 1 [/SUP], Ying Zou[SUP] 1 [/SUP], Jiefei Wang[SUP] 1 [/SUP], Yuyi Zhang[SUP] 1 [/SUP], Lie Xu[SUP] 3 [/SUP], Hongzhou Lu[SUP] 7 [/SUP]
Affiliations
- PMID: 34668629
- DOI: 10.1111/ajag.13003
Abstract
Objective: Myocardial injury leads to higher mortality in COVID-19, but the causes and risk factors are variable. We evaluated the potential risk factors for myocardial injury in COVID-19 patients to improve treatment strategies and reduce mortality.
Methods: This retrospective analysis enrolled 325 COVID-19 patients in Shanghai, China.
Results: The median age in our cohort was 51 [range 15-88] years, 26 (8%) were critically ill, and 177 patients (19.7%) had myocardial injury. The myocardial injury group comprised older, more critically ill patients with hypertension, other comorbidities, history of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use, lower peripheral blood lymphocyte count and higher D-dimer levels. Binary logistic regression analysis identified only age was an independent risk factor for myocardial injury (odds ratio 1.019; 95% confidence interval 1.003-1.036; age increase by 1 year = myocardial injury risk increase by 1.9%).
Conclusion: Older age was associated with a higher incidence of myocardial injury for COVID-19 patients.
Keywords: COVID-19; SARS-CoV-2; myocardial injury; novel coronavirus pneumonia.